Batard T, Nony E, Hrabina M, Chabre H, Frati F, Moingeon P
.
Eur Ann Allergy Clin Immunol. 2013 Oct 1;45 Suppl 2:33-7.
Relevant allergens are major contributors to the safety and efficacy of allergenic extracts used in allergen immunotherapy (AIT). As such, they should be accurately quantified, as recommended by the 2008 European guidelines on allergen products. Until now, the quantification of relevant allergens was mainly performed by using immunoassays (e.g. ELISA) that relying upon specific antibodies. Although antibody-based quantification is commonly used to assess the concentration of relevant allergens in allergenic extracts, results must be taken with caution in the light of the inherent limitations of such techniques. In the present study, we discuss how those limitations can be overcome by using comprehensive mass spectrometry-based techniques.
相关变应原是变应原免疫疗法(AIT)中所用变应原提取物安全性和有效性的主要决定因素。因此,按照2008年欧洲变应原产品指南的建议,应准确对其进行定量。到目前为止,相关变应原的定量主要通过使用依赖特异性抗体的免疫测定法(如酶联免疫吸附测定法)来进行。尽管基于抗体的定量常用于评估变应原提取物中相关变应原的浓度,但鉴于此类技术的固有局限性,对结果必须谨慎对待。在本研究中,我们讨论了如何通过使用基于质谱的综合技术来克服这些局限性。